Laparoscopic cytoreduction for primary advanced ovarian cancer

22Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Introduction: We evaluated the feasibility of laparoscopic cytoreduction for primary advanced ovarian cancer. Methods: All patients with presumed stage 3/4 primary ovarian cancer underwent attempted laparoscopic cytoreduction. All patients had CT evidence of omental metastasis and ascites. A 5-port (5-mm) transperitoneal approach was used. A bilateral salpingo-oophorectomy, supracervical hysterectomy, and omentectomy were performed with PlasmaKinetic (PK) cutting forceps. A laparoscopic 5-mm Argon-Beam Coagulator was used to coagulate tumor in the pelvis, abdominal peritoneum, intestinal mesentery, and diaphragm. Results: Nine of 11 cases (82%) were successfully debulked laparoscopically without conversion to laparotomy. Median operative time was 2.5 hours, and median blood loss was 275 mL. All tumors were debulked to <2 cm and 45% had no residual disease. Stages were 1-3B, 7-3C, and 1-4. Median length of stay was one day. Median VAS pain score was 4 (discomforting). Two of 11 patients (18%) had postoperative complications. Conclusion: Laparoscopic cytoreduction was successful and resulted in minimal morbidity. Because of our small sample size, additional studies are needed. © 2010 by JSLS, Journal of the Society of Laparoendoscopic Surgeons.

Cite

CITATION STYLE

APA

Fanning, J., Hojat, R., Johnson, J., & Fenton, B. (2010). Laparoscopic cytoreduction for primary advanced ovarian cancer. Journal of the Society of Laparoendoscopic Surgeons, 14(1), 80–82. https://doi.org/10.4293/108680810X12674612014707

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free